SAN JUAN, PUERTO RICO -- A novel regimen for platinum-resistant ovarian cancer solidified its role as a treatment option with ...

A research team led by scientists from the State University of Campinas (UNICAMP) in São Paulo, Brazil, has made significant ...

A research team led by Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, has published a comprehensive ...

A research team led by Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, has published a comprehensive ...

I initiate coverage on Forte Biosciences stock at a 'Hold' rating due to both pipeline risk and upcoming clinical catalysts.

A research team led by Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, has published a comprehensive review in ExRNA that sorts out ...

Far more than a superficial epithelial problem, corneal melt is a progressive ulceration of corneal stromal tissue that can compromise the structural integrity of the eye. Corneal melt often precedes ...

A new review reveals how focal adhesion kinase (FAK) acts as a central regulator of tumor progression and immune suppression ...

Booking Health, a global medical travel provider, announced today the release of its 2026 report on advanced head and neck ...

IL10 secretion accelerated corneal wound healing in mice, and IL10 receptor blockade abrogated benefit, supporting a ...

Vedanta Biosciences is a late clinical-stage biopharmaceutical company developing a new category of microbiome-based oral therapies for gastrointestinal diseases. Vedanta's lead program, VE303, is ...

Microplastics turned up in every human bile sample tested and pushed duct cells toward mitochondrial dysfunction and ...